Grant: Discovery Grants Program - Individual
Université de Montréal
$28,000.00
The endogenous cannabinoid system is involved in pain-reward opponent mechanisms
EF 2019-20
Résumé
Pain-reward interactions are complex. Several experimental studies have shown that a wide range of pleasant stimuli produce analgesic effects in humans. More recently, it has been shown that the cessation of pain stimulation produces pleasant responses in humans. Preliminary functional neuro-imaging studies have shown that reward-induced analgesia is associated with the activation of key regions of the brain reward system and de-activation of brain regions of the pain matrix. Conversely, it has been shown that the interruption of pain stimulation is not only associated with reduced activity in pain networks, but also increased activity in the brain reward system. In the current proposal, we will seek to show that the endogenous cannabinoid system - which mediates the effects of cannabis in the brain is a key mediator of pain-reward opponent processes. The endogenous cannabinoid system is composed of lipid ligands which mainly bind to two cannabinoid receptors, CB1 and CB2. Importantly, CB1 receptors are highly concentrated in the brain reward system and in key regions of the pain matrix. Here, we will perform 3 logically related broad sets of experiments. In the first part of the program, we will examine the influence of cannabininoid-1 receptor (CNR1) gene polymorphisms on experimental measures of “reward-induced analgesia” and “pain relief pleasantness” administered to 200 healthy volunteers. The objective of Part 1 is to identify the CNR1 gene polymorphism exerting the strongest influence on pain-reward opponent processes. In the second part of the program, we will scan 25 healthy volunteers using functional magnetic resonance imaging (fMRI). In the scanner, subjects will perform fMRI adaptations of the tasks administered in Part 1. The objective of Part 2 is to characterize the interactions (e.g. connectivity) between pain- and reward-related activations during tasks measuring pain-reward opponent processes. Finally, in the third part of the program, we will scan 50 participants having completed Part 1. Subjects will be divided in two sub-groups based on the CNR1 gene polymorphism emerging as being the most closely associated with task performance in Part1. We will recruit participants carrying the genotypes associated with low and high CB1 receptor functioning. In the scanner, participants will perform fMRI adaptations of the tasks performed in Part 1. The third objective of the program is to demonstrate the influence of CNR1 genotypes on brain activations elicited during both tasks. The influence of CNR1 genotypes on the connectivity between pain- and reward-related pathways will also be examined. By combining psychophysics, fMRI and behavioral genetics, the current proposal will provide crucial information on the neuro-chemical and neuro-functional mechanisms involved in pain-reward interactions.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2016-05719
Name nom
Potvin, Stéphane
Department département
Psychiatrie et d'addictologie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2016
Award amount
28000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
9000
Research subject group en
Medical sciences
Research subject group fr
Sciences médicales
Research subject en
Medical sciences
Research subject fr
Sciences médicales
Installment
inst:4 - 5
Partie
4
Nb partie
5
Application title
The endogenous cannabinoid system is involved in pain-reward opponent mechanisms
Keyword
NSERC
Application summary
Pain-reward interactions are complex. Several experimental studies have shown that a wide range of pleasant stimuli produce analgesic effects in humans. More recently, it has been shown that the cessation of pain stimulation produces pleasant responses in humans. Preliminary functional neuro-imaging studies have shown that reward-induced analgesia is associated with the activation of key regions of the brain reward system and de-activation of brain regions of the pain matrix. Conversely, it has been shown that the interruption of pain stimulation is not only associated with reduced activity in pain networks, but also increased activity in the brain reward system. In the current proposal, we will seek to show that the endogenous cannabinoid system - which mediates the effects of cannabis in the brain is a key mediator of pain-reward opponent processes. The endogenous cannabinoid system is composed of lipid ligands which mainly bind to two cannabinoid receptors, CB1 and CB2. Importantly, CB1 receptors are highly concentrated in the brain reward system and in key regions of the pain matrix. Here, we will perform 3 logically related broad sets of experiments. In the first part of the program, we will examine the influence of cannabininoid-1 receptor (CNR1) gene polymorphisms on experimental measures of “reward-induced analgesia” and “pain relief pleasantness” administered to 200 healthy volunteers. The objective of Part 1 is to identify the CNR1 gene polymorphism exerting the strongest influence on pain-reward opponent processes. In the second part of the program, we will scan 25 healthy volunteers using functional magnetic resonance imaging (fMRI). In the scanner, subjects will perform fMRI adaptations of the tasks administered in Part 1. The objective of Part 2 is to characterize the interactions (e.g. connectivity) between pain- and reward-related activations during tasks measuring pain-reward opponent processes. Finally, in the third part of the program, we will scan 50 participants having completed Part 1. Subjects will be divided in two sub-groups based on the CNR1 gene polymorphism emerging as being the most closely associated with task performance in Part1. We will recruit participants carrying the genotypes associated with low and high CB1 receptor functioning. In the scanner, participants will perform fMRI adaptations of the tasks performed in Part 1. The third objective of the program is to demonstrate the influence of CNR1 genotypes on brain activations elicited during both tasks. The influence of CNR1 genotypes on the connectivity between pain- and reward-related pathways will also be examined. By combining psychophysics, fMRI and behavioral genetics, the current proposal will provide crucial information on the neuro-chemical and neuro-functional mechanisms involved in pain-reward interactions.